Evidence-based risk assessment and known adverse effects
Risk Classification: High Risk
N-Phenethyl-Noroxymorphone (PHM) is associated with a high risk profile. Significant physical and psychological risks have been documented. Caution is warranted.
Aggregated from 3 verified experience reports. Community data reflects reported subjective experiences, not clinical outcomes.
Route of administration significantly influences the risk profile. Intravenous and inhalation routes carry substantially higher risks than oral administration. Commonly reported routes for N-Phenethyl-Noroxymorphone (PHM):
Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. If you have concerns about substance use, please consult a qualified healthcare professional or contact a local drug support service.